Sign in

CIK 0001628171

  • Large accelerated filer

Revolution Medicines, Inc.

Sign in to watch
Ticker
RVMD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472029180
Phone
+1 650-481-6801
Business address
700 SAGINAW DR, REDWOOD CITY, CA, 94063

Securities

  • RVMD Common Stock Nasdaq
  • RVMDW Warrant Nasdaq
  1. 4 Planned sale GOLDSMITH MARK A sold 11,715 shares at $44.19 ($517,631)
  2. 4 Planned sale Chief Operating Officer sold 4,331 shares at $44.19 ($191,367)
  3. 4 Planned sale Kelsey Stephen Michael sold 4,665 shares at $44.19 ($206,124)
  4. 4 Planned sale General Counsel sold 1,454 shares at $44.19 ($64,245)
  5. 4 Planned sale Kelsey Stephen Michael sold 16,667 shares at an average $43.32 ($722,087)
  6. 4 Returned to the company Director returned 1,808 shares (to the company)
  7. 4 Planned sale Kelsey Stephen Michael sold 16,667 shares at $42.98 ($716,389)
  8. 4 Grant or award Director acquired 6,932 shares (grant or award)
  9. 3 Insider Initial Statement of Ownership
  10. 4 Planned sale GOLDSMITH MARK A sold 10,000 shares at an average $45.88 ($458,827)
  11. 4 Planned sale Kelsey Stephen Michael sold 16,667 shares at an average $46.47 ($774,516)
  12. 4 Planned sale GOLDSMITH MARK A sold 35,000 shares at an average $45.04 ($1,576,322)
  13. 4 Planned sale General Counsel sold 2,399 shares at $40.83 ($97,951)
  14. 4 Planned sale Director sold 2,155 shares at $44.00 ($94,820)
  15. 4/A Grant or award Director acquired 4,248 shares (grant or award)
  16. 4/A Grant or award Director acquired 4,248 shares (grant or award)
  17. 4/A Grant or award Director acquired 4,248 shares (grant or award)
  18. 4/A Grant or award Director acquired 4,248 shares (grant or award)
  19. 4/A Grant or award Director acquired 4,248 shares (grant or award)
  20. 4/A Grant or award Director acquired 4,248 shares (grant or award)

Page 8 of 21 · 414 filings